Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Anupam Rama is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/12/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/15/2024 | SLDB | Buy Now | Solid Biosciences | $8.70 | 72.41% | $10 → $15 | Upgrade | Neutral → Overweight | Get Alert |
| 07/12/2024 | ZLAB | Buy Now | Zai Lab | $18.00 | 111.11% | $43 → $38 | Maintains | Overweight | Get Alert |
| 07/12/2024 | SAGE | Buy Now | Sage Therapeutics | $11.80 | 52.54% | $23 → $18 | Maintains | Overweight | Get Alert |
| 07/12/2024 | IDYA | Buy Now | IDEAYA Biosciences | $41.35 | 66.87% | $65 → $69 | Maintains | Overweight | Get Alert |
| 07/10/2024 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | 16.89% | $169 → $173 | Maintains | Overweight | Get Alert |
| 06/20/2024 | SAGE | Buy Now | Sage Therapeutics | $11.80 | 94.92% | $28 → $23 | Maintains | Overweight | Get Alert |
| 05/31/2024 | VERA | Buy Now | Vera Therapeutics | $36.75 | 76.87% | $60 → $65 | Maintains | Overweight | Get Alert |
| 05/31/2024 | SLDB | Buy Now | Solid Biosciences | $8.70 | 14.94% | $12 → $10 | Maintains | Neutral | Get Alert |
| 05/21/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $24.38 | 39.46% | $34 → $34 | Maintains | Overweight | Get Alert |
| 05/15/2024 | RLYB | Buy Now | Rallybio | $1.37 | — | — | Downgrade | Overweight → Neutral | Get Alert |
| 05/03/2024 | SRPT | Buy Now | Sarepta Therapeutics | $152.60 | 14.68% | $177 → $175 | Maintains | Overweight | Get Alert |
| 05/01/2024 | SAGE | Buy Now | Sage Therapeutics | $11.80 | 137.29% | $29 → $28 | Maintains | Overweight | Get Alert |
| 05/01/2024 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $21.61 | 38.82% | $26 → $30 | Maintains | Overweight | Get Alert |
| 04/22/2024 | DAWN | Buy Now | Day One Biopharmaceutical | $15.70 | 129.3% | $32 → $36 | Maintains | Overweight | Get Alert |
| 04/22/2024 | CTMX | Buy Now | CytomX Therapeutics | $1.43 | — | — | Upgrade | Underweight → Neutral | Get Alert |
| 04/01/2024 | ANAB | Buy Now | AnaptysBio | $32.71 | -14.4% | $30 → $28 | Maintains | Neutral | Get Alert |
| 04/01/2024 | ANNX | Buy Now | Annexon | $6.17 | 110.7% | $11 → $13 | Maintains | Overweight | Get Alert |
| 03/27/2024 | RAPT | Buy Now | RAPT Therapeutics | $3.56 | 265.17% | $15 → $13 | Maintains | Neutral | Get Alert |
| 03/27/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $10.75 | 67.44% | $19 → $18 | Maintains | Overweight | Get Alert |
| 03/26/2024 | SAGE | Buy Now | Sage Therapeutics | $11.80 | 145.76% | $24 → $29 | Maintains | Overweight | Get Alert |
| 03/20/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $24.38 | 39.46% | $31 → $34 | Maintains | Overweight | Get Alert |
| 03/20/2024 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | 6.76% | $148 → $158 | Maintains | Overweight | Get Alert |
| 03/20/2024 | BBIO | Buy Now | BridgeBio Pharma | $28.20 | 59.58% | $35 → $45 | Maintains | Overweight | Get Alert |
| 03/18/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $44.46 | 106.93% | $88 → $92 | Maintains | Overweight | Get Alert |
| 03/18/2024 | FOLD | Buy Now | Amicus Therapeutics | $10.57 | 79.75% | $21 → $19 | Maintains | Overweight | Get Alert |
| 03/06/2024 | SWTX | Buy Now | SpringWorks Therapeutics | $41.84 | 79.25% | $73 → $74 | Maintains | Overweight | Get Alert |
| 03/06/2024 | NUVL | Buy Now | Nuvalent | $81.45 | 20.32% | $68 → $98 | Maintains | Overweight | Get Alert |
| 03/06/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $39.98 | 97.6% | $78 → $79 | Maintains | Overweight | Get Alert |
| 03/01/2024 | ANNX | Buy Now | Annexon | $6.17 | 78.28% | $11 → $11 | Upgrade | Neutral → Overweight | Get Alert |
| 02/27/2024 | COGT | Buy Now | Cogent Biosciences | $9.25 | 116.22% | $18 → $20 | Maintains | Overweight | Get Alert |
| 02/23/2024 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | — | $154 → $148 | Maintains | Overweight | Get Alert |
| 02/23/2024 | IDYA | Buy Now | IDEAYA Biosciences | $41.35 | 37.85% | $51 → $57 | Maintains | Overweight | Get Alert |
| 02/21/2024 | RAPT | Buy Now | RAPT Therapeutics | $3.56 | 321.35% | $35 → $15 | Downgrade | Overweight → Neutral | Get Alert |
| 12/22/2023 | ALVR | Buy Now | AlloVir | $0.79 | — | — | Downgrade | Overweight → Underweight | Get Alert |
| 12/08/2023 | COGT | Buy Now | Cogent Biosciences | $9.25 | 94.59% | → $18 | Initiates | → Overweight | Get Alert |
| 11/30/2023 | VERA | Buy Now | Vera Therapeutics | $36.75 | -40.14% | $25 → $22 | Maintains | Overweight | Get Alert |
| 11/30/2023 | ZLAB | Buy Now | Zai Lab | $18.00 | 266.67% | $64 → $66 | Maintains | Overweight | Get Alert |
| 11/30/2023 | RAPT | Buy Now | RAPT Therapeutics | $3.56 | 883.15% | $32 → $35 | Maintains | Overweight | Get Alert |
| 11/30/2023 | IDYA | Buy Now | IDEAYA Biosciences | $41.35 | -0.85% | $35 → $41 | Maintains | Overweight | Get Alert |
| 10/31/2023 | SRPT | Buy Now | Sarepta Therapeutics | $152.60 | -24.64% | $211 → $115 | Maintains | Overweight | Get Alert |
| 10/17/2023 | ZLAB | Buy Now | Zai Lab | $18.00 | 255.56% | $67 → $64 | Maintains | Overweight | Get Alert |
| 10/17/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $24.38 | 55.87% | $36 → $38 | Maintains | Overweight | Get Alert |
| 10/06/2023 | GTHX | Buy Now | G1 Therapeutics | $3.24 | — | — | Downgrade | Neutral → Underweight | Get Alert |
| 10/06/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $39.98 | 102.6% | $60 → $81 | Upgrade | Neutral → Overweight | Get Alert |
| 10/05/2023 | NUVL | Buy Now | Nuvalent | $81.45 | -16.51% | $51 → $68 | Maintains | Overweight | Get Alert |
| 09/29/2023 | FOLD | Buy Now | Amicus Therapeutics | $10.57 | 79.75% | $17 → $19 | Maintains | Overweight | Get Alert |
| 09/15/2023 | OLMA | Buy Now | Olema Pharmaceuticals | $13.14 | 44.6% | $16 → $19 | Maintains | Overweight | Get Alert |
| 09/13/2023 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | -9.46% | $133 → $134 | Maintains | Overweight | Get Alert |
| 08/17/2023 | BBIO | Buy Now | BridgeBio Pharma | $28.20 | 34.75% | $42 → $38 | Maintains | Overweight | Get Alert |
| 08/17/2023 | IDYA | Buy Now | IDEAYA Biosciences | $41.35 | -22.61% | $28 → $32 | Maintains | Overweight | Get Alert |
| 08/16/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $24.38 | 35.36% | $36 → $33 | Maintains | Overweight | Get Alert |
| 08/16/2023 | RAPT | Buy Now | RAPT Therapeutics | $3.56 | 798.88% | $39 → $32 | Maintains | Overweight | Get Alert |
| 08/16/2023 | GBIO | Buy Now | Generation Bio | $2.93 | 207.17% | $8 → $9 | Maintains | Neutral | Get Alert |
| 08/10/2023 | RLYB | Buy Now | Rallybio | $1.37 | 1213.87% | $17 → $18 | Maintains | Overweight | Get Alert |
| 08/10/2023 | OLMA | Buy Now | Olema Pharmaceuticals | $13.14 | 21.77% | $14 → $16 | Maintains | Overweight | Get Alert |
| 08/03/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $39.98 | 50.08% | $72 → $60 | Downgrade | Overweight → Neutral | Get Alert |
| 07/25/2023 | KOD | Buy Now | Kodiak Sciences | $3.00 | — | — | Downgrade | Neutral → Underweight | Get Alert |
| 07/21/2023 | TVTX | Buy Now | Travere Therapeutics | $9.78 | 165.85% | → $26 | Initiates | → Overweight | Get Alert |
| 07/20/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $39.98 | 80.09% | $100 → $72 | Maintains | Overweight | Get Alert |
| 06/23/2023 | SRPT | Buy Now | Sarepta Therapeutics | $152.60 | 39.58% | $217 → $213 | Maintains | Overweight | Get Alert |
| 06/23/2023 | NUVL | Buy Now | Nuvalent | $81.45 | -41.07% | $37 → $48 | Maintains | Overweight | Get Alert |
| 06/15/2023 | REPL | Buy Now | Replimune Group | $10.81 | 362.53% | $38 → $50 | Maintains | Overweight | Get Alert |
| 05/25/2023 | ANNX | Buy Now | Annexon | $6.17 | 45.87% | $19 → $9 | Downgrade | Overweight → Neutral | Get Alert |
| 05/22/2023 | ANAB | Buy Now | AnaptysBio | $32.71 | -8.28% | $31 → $30 | Upgrade | Underweight → Neutral | Get Alert |
| 04/12/2023 | VERA | Buy Now | Vera Therapeutics | $36.75 | -40.14% | $38 → $22 | Maintains | Overweight | Get Alert |
| 04/12/2023 | ANAB | Buy Now | AnaptysBio | $32.71 | -5.23% | $32 → $31 | Maintains | Underweight | Get Alert |
| 04/04/2023 | KOD | Buy Now | Kodiak Sciences | $3.00 | 233.33% | $12 → $10 | Maintains | Neutral | Get Alert |
| 03/21/2023 | RAPT | Buy Now | RAPT Therapeutics | $3.56 | 1079.78% | $48 → $42 | Maintains | Overweight | Get Alert |
| 03/21/2023 | ORIC | Buy Now | ORIC Pharmaceuticals | $10.75 | 39.53% | $16 → $15 | Maintains | Overweight | Get Alert |
| 03/16/2023 | ZLAB | Buy Now | Zai Lab | $18.00 | 288.89% | $79 → $70 | Maintains | Overweight | Get Alert |
| 03/09/2023 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $21.61 | -7.45% | $19 → $20 | Maintains | Overweight | Get Alert |
| 03/07/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $24.38 | 47.66% | $41 → $36 | Maintains | Overweight | Get Alert |
| 03/07/2023 | SWTX | Buy Now | SpringWorks Therapeutics | $41.84 | 36.23% | $53 → $57 | Maintains | Overweight | Get Alert |
| 03/07/2023 | BBIO | Buy Now | BridgeBio Pharma | $28.20 | -18.44% | $18 → $23 | Maintains | Overweight | Get Alert |
| 03/03/2023 | SRPT | Buy Now | Sarepta Therapeutics | $152.60 | 34.99% | $153 → $206 | Maintains | Overweight | Get Alert |
| 01/30/2023 | GTHX | Buy Now | G1 Therapeutics | $3.24 | 208.64% | $7 → $10 | Upgrade | Underweight → Neutral | Get Alert |
| 01/20/2023 | CYT | Buy Now | Cyteir Therapeutics | — | — | — | Downgrade | Overweight → Neutral | Get Alert |
| 01/03/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $24.38 | 68.17% | → $41 | Initiates | → Overweight | Get Alert |
| 12/09/2022 | RLYB | Buy Now | Rallybio | $1.37 | 1432.85% | → $21 | Initiates | → Overweight | Get Alert |
| 12/06/2022 | SAGE | Buy Now | Sage Therapeutics | $11.80 | 408.47% | $92 → $60 | Maintains | Overweight | Get Alert |
| 11/18/2022 | ZLAB | Buy Now | Zai Lab | $18.00 | 338.89% | $96 → $79 | Maintains | Overweight | Get Alert |
| 11/18/2022 | BBIO | Buy Now | BridgeBio Pharma | $28.20 | -32.62% | $20 → $19 | Maintains | Overweight | Get Alert |
| 11/18/2022 | VERA | Buy Now | Vera Therapeutics | $36.75 | 3.4% | $35 → $38 | Maintains | Overweight | Get Alert |
| 11/18/2022 | ANAB | Buy Now | AnaptysBio | $32.71 | -2.17% | $24 → $32 | Maintains | Underweight | Get Alert |
| 11/15/2022 | APLS | Buy Now | Apellis Pharmaceuticals | $39.98 | 97.6% | $81 → $79 | Maintains | Overweight | Get Alert |
| 11/10/2022 | ELEV | Buy Now | Elevation Oncology | $3.05 | — | — | Downgrade | Neutral → Underweight | Get Alert |
| 11/10/2022 | CTMX | Buy Now | CytomX Therapeutics | $1.43 | — | — | Downgrade | Overweight → Underweight | Get Alert |
| 11/03/2022 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | -3.38% | $138 → $143 | Maintains | Overweight | Get Alert |
| 09/30/2022 | SLDB | Buy Now | Solid Biosciences | $8.70 | — | — | Upgrade | Underweight → Neutral | Get Alert |
| 09/26/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | $109 → $94 | Maintains | Overweight | Get Alert |
| 08/08/2022 | ELEV | Buy Now | Elevation Oncology | $3.05 | — | — | Downgrade | Overweight → Neutral | Get Alert |
| 07/13/2022 | ATRA | Buy Now | Atara Biotherapeutics | $11.50 | -13.04% | → $250 | Downgrade | Overweight → Neutral | Get Alert |
| 07/12/2022 | VERA | Buy Now | Vera Therapeutics | $36.75 | -4.76% | → $35 | Initiates | → Overweight | Get Alert |
| 04/04/2022 | ZLAB | Buy Now | Zai Lab | $18.00 | 522.22% | $136 → $112 | Maintains | Overweight | Get Alert |
| 04/04/2022 | REPL | Buy Now | Replimune Group | $10.81 | 260.78% | $47 → $39 | Maintains | Overweight | Get Alert |
| 04/04/2022 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | -14.86% | $125 → $126 | Maintains | Overweight | Get Alert |
| 04/04/2022 | APLS | Buy Now | Apellis Pharmaceuticals | $39.98 | 72.59% | $66 → $69 | Maintains | Overweight | Get Alert |
| 03/28/2022 | ATRA | Buy Now | Atara Biotherapeutics | $11.50 | 91.3% | $675 → $550 | Maintains | Overweight | Get Alert |
| 03/11/2022 | BBIO | Buy Now | BridgeBio Pharma | $28.20 | -36.17% | $21 → $18 | Maintains | Overweight | Get Alert |
| 03/08/2022 | PASG | Buy Now | Passage Bio | $0.92 | — | — | Downgrade | Overweight → Neutral | Get Alert |
| 02/24/2022 | KOD | Buy Now | Kodiak Sciences | $3.00 | 600% | $90 → $21 | Downgrade | Overweight → Neutral | Get Alert |
| 02/02/2022 | KOD | Buy Now | Kodiak Sciences | $3.00 | 2900% | → $90 | Upgrade | Neutral → Overweight | Get Alert |
| 01/03/2022 | ATRA | Buy Now | Atara Biotherapeutics | $11.50 | 134.78% | $650 → $675 | Maintains | Overweight | Get Alert |
| 12/10/2021 | CYTK | Buy Now | Cytokinetics | $57.39 | 1.06% | — | Initiates | → Overweight | Get Alert |
| 12/09/2021 | RAPT | Buy Now | RAPT Therapeutics | $3.56 | 1613.48% | — | Initiates | → Overweight | Get Alert |
| 11/17/2021 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | -16.22% | — | Upgrade | Neutral → Overweight | Get Alert |
| 11/16/2021 | ORTX | Buy Now | Orchard Therapeutics | — | — | — | Downgrade | Neutral → Underweight | Get Alert |
| 05/13/2021 | ATRA | Buy Now | Atara Biotherapeutics | $11.50 | 152.17% | $575 → $725 | Upgrade | Neutral → Overweight | Get Alert |
| 01/27/2021 | FREQ | Buy Now | Frequency Therapeutics | — | — | → $2800 | Upgrade | Neutral → Overweight | Get Alert |
| 05/18/2020 | FREQ | Buy Now | Frequency Therapeutics | — | — | → $1350 | Downgrade | Overweight → Neutral | Get Alert |
| 05/12/2020 | ATRA | Buy Now | Atara Biotherapeutics | $11.50 | 100% | $550 → $575 | Maintains | Neutral | Get Alert |
| 03/27/2020 | FREQ | Buy Now | Frequency Therapeutics | — | — | $1300 → $1400 | Maintains | Overweight | Get Alert |
| 11/08/2019 | ATRA | Buy Now | Atara Biotherapeutics | $11.50 | 91.3% | $1075 → $550 | Downgrade | Overweight → Neutral | Get Alert |
| 10/28/2019 | FREQ | Buy Now | Frequency Therapeutics | — | — | → $1250 | Initiates | → Overweight | Get Alert |
| 04/10/2018 | ATRA | Buy Now | Atara Biotherapeutics | $11.50 | 386.96% | → $1400 | Initiates | → Overweight | Get Alert |
